Rogue Funds, an investment management company, released its fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund returned 8.59% net of fees in the quarter.
Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...
PracticeLink, the nation’s most trusted physician recruitment resource and home of the most widely used online physician job board, is pleased to announce the launch of PracticeLink PRO Marketing, the ...
Beyond written content, a pleasant, approachable video outlining a procedure or healthy living tips can also build greater ...
Discover how Boston Medical Center Health System is unifying its brand and integrating two former Steward Health Care hospitals through successful marketing.
1dOpinion
MedPage Today on MSNAn Open Letter to RFK Jr.: Stop the Spread of Private Equity in HealthcarePrivate equity (PE) is the fastest-growing malignancy of the American healthcare system. In your new position as secretary of ...
Washington University's Olin School of Business is trying to streamline communication between people who specialize in health ...
Elanco Animal Health (NYSE:ELAN) has received a warning letter from the FDA related to promotional materials for its canine drug Zenrelia. In the letter, the FDA said that an agency review of certain ...
Meet Molly Biwer, the new chief marketing officer of Emory Healthcare. With a wealth of experience and creative approach, she's set to elevate the organization.
(“Journey Medical”), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing U.S. Food and Drug Administration (“FDA”)-approved prescription ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results